nabios Gesellschaft fuer medizinische Datenanalysen mbH
nabios Gesellschaft fuer medizinische Datenanalysen mbH is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
[22961] A placebo-controlled, parallel-group, double blind, randomized, multi-cohort Phase 2 study to investigate efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics of BAY 3670549 in adult participants with atrial fibrillation.
Sponsor Bayer AG
- Start (EU)
- Latest update
- Estimated end
(22040 ALPINE 1) A Phase 2b dose-finding, randomized, placebo-controlled, double-blind study to evaluate efficacy and safety of BAY 3283142 on top of standard of care in reducing albuminuria in patients with chronic kidney disease
Sponsor Bayer AG
- Start (EU)
- Latest update
- Estimated end
(21751) First-in-human single dose escalation study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of BAY 3018250 in healthy men in a randomized, placebo-controlled, single-blind, group-comparison design
Sponsor Bayer AG
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for nabios Gesellschaft fuer medizinische Datenanalysen mbH?
The 2026-10-09 snapshot links nabios Gesellschaft fuer medizinische Datenanalysen mbH to 3 distinct CTIS trials. Recorded services include Cardiac services, Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for nabios Gesellschaft fuer medizinische Datenanalysen mbH?
The most frequently recorded therapeutic areas are Cardiology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to nabios Gesellschaft fuer medizinische Datenanalysen mbH conducted?
The linked trials record locations in 12 countries, including Belgium, Germany, Italy, Bulgaria, Spain. These are trial locations, not confirmed office locations or countries where nabios Gesellschaft fuer medizinische Datenanalysen mbH delivered services.
What can this page tell me about nabios Gesellschaft fuer medizinische Datenanalysen mbH's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under nabios Gesellschaft fuer medizinische Datenanalysen mbH. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Nabios Gesellschaft fuer medizinische Datenanalysen mbH
- nabios Gesellschaft fuer medizinische Datenanalysen mbH